QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
A new conceptual framework in psoriasis
Check out this recent publication from Quantify, presenting a new conceptual framework in psoriasis that differentiates psoriasis severity from disease control (Link to article: https://onlinelibrary.wiley.com/doi/10.1111/bjd.21023https://lnkd.in/gJtZtENB). Authored by Quantify’s CEO Kirk Geale, this article published in the British Journal of Dermatology is a step forward in modernizing the way we view psoriasis within today’s treatment paradigm. We hope this new approach […]
8 March – International Women’s Day
“Struck by a chicken”
At Quantify, we work a lot with ICD codes. And we mean a lot! So much, in fact, that we have discovered some pretty obscure codes that you might not be aware of. Our favourite code is W61.32 – “Struck by chicken.” Found in the external causes of morbidity and mortality chapter, most physicians know that this code should not be […]
28 Feb – Rare Disease Day
The 28th February is #rarediseaseday and we at Quantify want to help spread awareness of this important day as an estimated 300 million people of the world’s population are currently living with a rare disease.
At Quantify we are determined to improve the lives of patients all over the globe, and to help create a world where healthcare is evidence-based and patient-centric. Head on over to our homepage to read […]